drugset / Trial / NCT06005207
Vaginal Progesterone Improves Clinical Outcomes of RIF Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a single-center, randomized, controlled prospective study. Those patients with repeated implantation failure (RIF) who will recieve frozen thawed embryo transfer (FET) are enrolled in the study. To determine the effect of vaginal progesterone on the clinical pregnancy outcomes of RIF patients.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 90 mg | Other |